Legal Representation
Attorney
John Guynn
USPTO Deadlines
Application History
47 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jan 3, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Jan 2, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
May 31, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Apr 5, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Apr 5, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Mar 16, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Mar 1, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Mar 1, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Mar 1, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Mar 1, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Mar 1, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Feb 8, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Oct 27, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Oct 27, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Oct 27, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Oct 27, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Aug 18, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 16, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jul 19, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jul 13, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jul 12, 2021 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
Jul 12, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 12, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Jan 12, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Jan 12, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Dec 28, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Dec 28, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Dec 28, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jun 27, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jun 27, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Jun 27, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jun 9, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jun 8, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jun 8, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 30, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jan 30, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Jan 30, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jan 9, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jan 8, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jan 8, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jul 10, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jul 10, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jul 10, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jul 1, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 16, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Aug 16, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Aug 11, 2018 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Dietary and nutritional supplements featuring beta-hydroxybutyrate esters, acetoacetate, acetoacetate esters, and precursors thereof such as 1,3-butanediol, medium chain triglycerides, medium chain fatty acids, and medium chain fatty acid esters, in combination with hemp-derived cannabinoids, namely, cannabidiol and tetrahydrocannabinol; all of the foregoing goods contain hemp and not more than naturally occurring trace amounts of cannabidiol (CBD) that are solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005